Deerfield Private Design Fund III, L.P.
SEC CIK 1603333 · EDGAR
BoughtSold
Most active insiders at SPRY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Chakma Justin | Chief Business Off | — | $1.48M |
| 2 | Karas Eric | Chief Commercial Off | — | $250.0K |
| 3 | Dorsey Brian | COO | — | $190.1K |
| 4 | Fitzpatrick Alexander A | CLO | — | $33.5K |
| 5 | Shah Pratik | Dir | — | — |
Deerfield Private Design Fund III, L.P. made no open-market trades at SPRY in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-11-13 | 2024-11-11+ | SPRY | ARS Pharmaceuticals, Inc. | Deerfield Private Design Fund III, L.P. | 10% | S - Sale | $18.01 | -563.3K | 5.27M | -10% | -$10.14M |
| DMI | 2024-02-08 | 2024-02-06 | GUTS | FRACTYL HEALTH, INC. | Deerfield Private Design Fund III, L.P. | 10%, Possible Members of 10% Group | C - Cnv Deriv | — | +834.3K | 834.3K | New | — |
Purchase Sale Sale after option exercise All abbreviations